Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005192382 | SCV005829996 | pathogenic | Hereditary spastic paraplegia 48 | 2024-12-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu500Glnfs*31) in the AP5Z1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP5Z1 are known to be pathogenic (PMID: 20613862, 27606357). This variant is present in population databases (rs754345952, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. For these reasons, this variant has been classified as Pathogenic. |